[EN] FUSED HETEROAROMATIC PYRROLIDINONES AS SYK INHIBITORS<br/>[FR] PYRROLIDINONES ACCOLÉS EN TANT D'INHIBITEURS DE SYK
申请人:TAKEDA PHARMACEUTICAL
公开号:WO2011079051A1
公开(公告)日:2011-06-30
Disclosed are compounds of Formula 1, and pharmaceutically acceptable salts thereof, wherein G, L1, L2, R1, R2, R3, and R4 are defined in the specification. This disclosure also relates to materials and methods for preparing compounds of Formula 1, pharmaceutical compositions containing them, and their use for treating disorders, diseases, and conditions involving the immune system and inflammation, including rheumatoid arthritis, hematological malignancies, epithelial cancers (i.e., carcinomas), and other disorders, diseases, and conditions for which inhibition of SYK is indicated.